All Stories

  1. Youth depression: An overview of genetic findings and the challenge of heterogeneity
  2. Early Manifestations of Neurodevelopmental Copy Number Variants in Children: A Population-Based Investigation
  3. Study Preregistration: Clinical and Cognitive Mediators Underlying Subsequent Depression in Individuals With Attention-Deficit/Hyperactivity Disorder: A Developmental Approach
  4. Child Mental Health Research in Low- and Middle-Income Countries: A Twin-Family Feasibility Study in Nigeria
  5. Investigating the Symptom Presentation of Depression in Children With ADHD
  6. Reflections on the manifestation of attention-deficit hyperactivity disorder in girls from young adults with lived experiences: a qualitative study
  7. Mapping phenotypic and genetic relationships among irritability, depression and ADHD in adolescence using network analysis
  8. Measuring irritability across childhood, adolescence, and young adulthood: an investigation of measurement invariance by age, sex, and informant
  9. Exploring the mental health research priorities of parents with depression and their children
  10. Skills for adolescent WELLbeing (SWELL): protocol for a preventive effectiveness randomised controlled trial for young people at high-familial risk of depression with treatment optimisation for parents with depression at study entry comparing online gr...
  11. An item-level systematic review of the presentation of ADHD in females
  12. Professorships in child and adolescent psychiatry relative to a similarly sized medical specialty in the UK and Ireland: cross-sectional study
  13. Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies
  14. Neurofeedback for Attention-Deficit/Hyperactivity Disorder
  15. Correction: Validation of the Strengths and Difficulties Questionnaire (SDQ) emotional subscale in assessing depression and anxiety across development
  16. Long-term physical health conditions and youth anxiety and depression: Is there a causal link?
  17. The impact of published guidance on trends in the pharmacological management of depression in children and adolescents- a whole population e-cohort data linkage study in Wales, UK
  18. Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD – are we there yet?
  19. Investigating the neurodevelopmental correlates of early adolescent-onset emotional problems
  20. Polygenic liabilities and treatment trajectories in early-onset depression: a Danish register-based study
  21. Testing maternal effects of vitamin-D and omega-3 levels on offspring neurodevelopmental traits in the Norwegian Mother, Father and Child Cohort Study
  22. The unequal impacts of the COVID‐19 pandemic on young adults' mental health. Predictors of vulnerability and resilience using longitudinal birth cohort data in the UK
  23. Medication adherence and persistence in children and adolescents with attention deficit hyperactivity disorder (ADHD): a systematic review and qualitative update
  24. Sex differences in attention‐deficit hyperactivity disorder diagnosis and clinical care: a national study of population healthcare records in Wales
  25. Emotional problems across development: examining measurement invariance across childhood, adolescence and early adulthood
  26. Irritability in Youths: A Critical Integrative Review
  27. Peter McGuffin CBE (February 4, 1949–January 30, 2024)
  28. Childhood correlates and young adult outcomes of trajectories of emotional problems from childhood to adolescence
  29. Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: Evidence From Multiple Genetically Informed Designs
  30. Rare X-linked variants carry predominantly male risk in autism, Tourette syndrome, and ADHD
  31. Association between relative age at school and persistence of ADHD in prospective studies: an individual participant data meta-analysis
  32. Estimating the impact of transmitted and non-transmitted psychiatric and neurodevelopmental polygenic scores on youth emotional problems
  33. Irritability in Youth: A Critical Integrative Review
  34. Sex differences in ADHD diagnosis and clinical care: A national study of population healthcare records in Wales
  35. Young Adult ADHD Symptoms in the General Population and Neurocognitive Impairment
  36. Practitioner Review: Clinical utility of the QbTest for the assessment and diagnosis of attention‐deficit/hyperactivity disorder – a systematic review and meta‐analysis
  37. Networks of Neurodevelopmental Traits, Socioenvironmental Factors, Emotional Dysregulation in Childhood, and Depressive Symptoms Across Development in Two U.K. Cohorts
  38. Corrigendum to “Characterising depression trajectories in young people at high familial risk of depression” [J. Affect. Disord. 337 (2023) 66–74 (15 September)]
  39. Characterising depression trajectories in young people at high familial risk of depression
  40. Can a nation-wide e-cohort of ADHD and ASD in childhood be established using Welsh routinely available datasets?
  41. Validation of the Strengths and Difficulties Questionnaire (SDQ) emotional subscale in assessing depression and anxiety across development
  42. Stratifying early‐onset emotional disorders: using genetics to assess persistence in young people of European and South Asian ancestry
  43. Childhood attention-deficit hyperactivity disorder problems and mid-life cardiovascular risk: prospective population cohort study
  44. Cross-cohort change in parent-reported emotional problem trajectories across childhood and adolescence in the UK
  45. Estimating the impact of transmitted and non-transmitted psychiatric and neurodevelopmental polygenic scores on youth emotional problems
  46. Developmental manifestations of polygenic risk for bipolar disorder from infancy to middle childhood
  47. Co‐development of attention deficit hyperactivity disorder and autistic trait trajectories from childhood to early adulthood
  48. Following the children of depressed parents from childhood to adult life: A focus on mood and anxiety disorders
  49. Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected Parents
  50. Validation of the Strengths and Difficulties Questionnaire (SDQ) emotional subscale in assessing depression and anxiety across development
  51. Computerized cognitive training in attention-deficit/hyperactivity disorder (ADHD): a meta-analysis of randomized controlled trials with blinded and objective outcomes
  52. An agenda for future research regarding the mental health of young people with care experience
  53. Author Correction: Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains
  54. Mental-health before and during the COVID-19 pandemic in adults with neurodevelopmental disorders
  55. Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic
  56. DRAGON-Data: a platform and protocol for integrating genomic and phenotypic data across large psychiatric cohorts
  57. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains
  58. Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder
  59. ADHD and Autism Spectrum Disorder (ASD) in Childhood: establishing the feasibility and validity of a nation-wide e-cohort
  60. Latent bipolar depression – Authors' reply
  61. Investigating Direct and Indirect Genetic Effects in Attention-Deficit/Hyperactivity Disorder Using Parent-Offspring Trios
  62. Using genetic designs to identify likely causal environmental contributions to psychopathology
  63. Disentangling the influences of parental genetics on offspring's cognition, education, and psychopathology via genetic and phenotypic pathways
  64. Rare Maternally Inherited Coding Variants on Chromosome X Carry Predominantly Male Risk in Autism, Tourette Syndrome, and Attention-deficit/Hyperactivity Disorder
  65. Developing and validating a prediction model of adolescent major depressive disorder in the offspring of depressed parents
  66. Preschool development, temperament and genetic liability as early markers of childhood ADHD: A cohort study
  67. Practitioner Review: Attention‐deficit hyperactivity disorder and autism spectrum disorder – the importance of depression
  68. Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and Schizophrenia
  69. Depression in young people
  70. Longitudinally stable, brain‐based predictive models mediate the relationships between childhood cognition and socio‐demographic, psychological and genetic factors
  71. Early manifestations of genetic liability for ADHD, autism and schizophrenia at ages 18 and 24 months
  72. Motivation and Cognitive Abilities as Mediators Between Polygenic Scores and Psychopathology in Children
  73. Mental-health before and during the COVID-19 pandemic in adults with neurodevelopmental disorders
  74. Understanding de novo onset of anxiety during COVID‐19: Pre‐pandemic socio‐emotional functioning in vulnerable children
  75. Investigating direct and indirect genetic effects in attention deficit hyperactivity disorder (ADHD) using parent-offspring trios
  76. Decline in attention-deficit hyperactivity disorder traits over the life course in the general population: trajectories across five population birth cohorts spanning ages 3 to 45 years
  77. Investigating the associations between irritability and hot and cool executive functioning in those with ADHD
  78. Collecting genetic samples and linked mental health data from adolescents in schools: protocol coproduction and a mixed-methods pilot of feasibility and acceptability
  79. DRAGON-Data: A platform and protocol for integrating genomic and phenotypic data across large psychiatric cohorts
  80. “Late-onset” ADHD symptoms in young adulthood: Is this ADHD?
  81. Sleep disturbances in ADHD: investigating the contribution of polygenic liability for ADHD and sleep-related phenotypes
  82. Early-Life Injuries and the Development of Attention-Deficit/Hyperactivity Disorder
  83. Genetics of Attention-Deficit Hyperactivity Disorder
  84. Association of school absence and exclusion with recorded neurodevelopmental disorders, mental disorders, or self-harm: a nationwide, retrospective, electronic cohort study of children and young people in Wales, UK
  85. The antecedents and outcomes of persistent and remitting adolescent depressive symptom trajectories: a longitudinal, population-based English study
  86. ADHD in adults with recurrent depression
  87. Validation of the short Mood and Feelings Questionnaire in young adulthood
  88. Assessment of age-at-onset criterion for adult attention-deficit hyperactivity disorder
  89. Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression
  90. Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD
  91. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
  92. Variable Emergence of Autism Spectrum Disorder Symptoms From Childhood to Early Adulthood
  93. Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood
  94. The neurodiversity concept: is it helpful for clinicians and scientists?
  95. Exploring ADHD Symptoms and Associated Impairment across Development
  96. Is genetic liability to ADHD and ASD causally linked to educational attainment?
  97. Correction to: Examining the Role of Genetic Risk and Longitudinal Transmission Processes Underlying Maternal Parenting and Psychopathology and Children’s ADHD Symptoms and Aggression: Utilizing the Advantages of a Prospective Adoption Design
  98. ADHD and autism symptoms in youth: a network analysis
  99. Sex differences in anxiety and depression in children with attention deficit hyperactivity disorder: Investigating genetic liability and comorbidity
  100. Investigating regions of shared genetic variation in attention deficit/hyperactivity disorder and major depressive disorder: a GWAS meta-analysis
  101. Investigating Friendship Difficulties in the Pathway from ADHD to Depressive Symptoms. Can Parent–Child Relationships Compensate?
  102. Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression
  103. Longitudinally stable, brain-based predictive models mediate the relationships between childhood cognition and socio-demographic, psychological and genetic factors
  104. Author Correction: Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder
  105. ADHD in adults with recurrent depression
  106. Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood
  107. Validation of the short Mood and Feelings Questionnaire in young adulthood
  108. Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder
  109. What has happened to children's wellbeing in the UK?
  110. The Effect of Attention Deficit/Hyperactivity Disorder on Physical Health Outcomes: A 2-Sample Mendelian Randomization Study
  111. Development of ADHD: Etiology, Heterogeneity, and Early Life Course
  112. Collecting genetic samples and linked mental health data from adolescents in schools: Protocol co-production and a mixed-methods pilot of feasibility and acceptability
  113. Genetic Advances in Autism
  114. ADHD: Progressing From Genetic Discoveries to Biological Insights
  115. A Digital Intervention for Adolescent Depression (MoodHwb): Mixed Methods Feasibility Evaluation
  116. Investigating attention‐deficit hyperactivity disorder and autism spectrum disorder traits in the general population: What happens in adult life?
  117. Examining the Role of Genetic Risk and Longitudinal Transmission Processes Underlying Maternal Parenting and Psychopathology and Children’s ADHD Symptoms and Aggression: Utilizing the Advantages of a Prospective Adoption Design
  118. Pilot study to establish a prospective neonatal cohort: Study of Preterm Infants and Neurodevelopmental Genes (SPRING)
  119. Genetic Associations Between Childhood Psychopathology and Adult Depression and Associated Traits in 42 998 Individuals
  120. Motivation and Cognitive Abilities as Mediators between Polygenic Scores and Psychopathology in Children
  121. The ADHD paper that triggered a backlash, and what it taught me
  122. A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder
  123. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank
  124. Investigating regions of shared genetic variation in attention deficit/hyperactivity disorder and major depressive disorder: A GWAS meta-analysis
  125. ADHD and depression: investigating a causal explanation
  126. Family-Based Designs that Disentangle Inherited Factors from Pre- and Postnatal Environmental Exposures: In Vitro Fertilization, Discordant Sibling Pairs, Maternal versus Paternal Comparisons, and Adoption Designs
  127. Contribution of de novo and inherited rare CNVs to very preterm birth
  128. Is genetic liability to ADHD and ASD causally linked to educational attainment?
  129. Using a cross-cohort comparison design to test the role of maternal smoking in pregnancy in child mental health and learning: evidence from two UK cohorts born four decades apart
  130. The importance of a developmental perspective in Psychiatry: what do recent genetic-epidemiological findings show?
  131. What explains the link between childhood ADHD and adolescent depression? Investigating the role of peer relationships and academic attainment
  132. Infant Neuromotor Development: An Early Indicator of Genetic Liability for Neurodevelopmental Disorders
  133. Recent advances in the genetics of preterm birth
  134. Disentangling nature from nurture in examining the interplay between parent–child relationships, ADHD, and early academic attainment
  135. A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder
  136. Using Genetics to Examine a General Liability to Childhood Psychopathology
  137. Genetic liability to ADHD and substance use disorders in individuals with ADHD
  138. Controlled Antenatal Thyroid Screening II: Effect of Treating Maternal Suboptimal Thyroid Function on Child Behavior
  139. Identifying Novel Types of Irritability Using a Developmental Genetic Approach
  140. Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures
  141. A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample - ERRATUM
  142. Adult mood problems in children with neurodevelopmental problems: evidence from a prospective birth cohort followed to age 50
  143. A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample
  144. A cross-disorder MR-pheWAS of 5 major psychiatric disorders in UK Biobank
  145. ADHD genetic liability and physical health outcomes - A two-sample Mendelian randomization study
  146. Cross‐cohort change in adolescent outcomes for children with mental health problems
  147. Childhood neurodevelopmental difficulties and risk of adolescent depression: the role of irritability
  148. Irritability in ADHD: association with later depression symptoms
  149. Do natural experiments have an important future in the study of mental disorders?
  150. Adolescent and adult differences in major depression symptom profiles
  151. Developmental Contributions of Schizophrenia Risk Alleles and Childhood Peer Victimization to Early-Onset Mental Health Trajectories
  152. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
  153. Advances in our understanding of the genetics of childhood neurodevelopmental disorders
  154. Characterizing Developmental Trajectories and the Role of Neuropsychiatric Genetic Risk Variants in Early-Onset Depression
  155. Identifying novel subtypes of irritability using a developmental genetic approach
  156. Discoveries on the Genetics of ADHD in the 21st Century: New Findings and Their Implications
  157. The contribution of psychiatric risk alleles to a general liability to psychopathology in early life
  158. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome
  159. Identifying the contribution of prenatal risk factors to offspring development and psychopathology: What designs to use and a critique of literature on maternal smoking and stress in pregnancy
  160. Facial Emotion Recognition and Eye Gaze in Attention-Deficit/Hyperactivity Disorder With and Without Comorbid Conduct Disorder
  161. Resilience in high-risk adolescents of mothers with recurrent depressive disorder: The contribution of fathers
  162. A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder
  163. Psychoeducational interventions in adolescent depression: A systematic review
  164. Association of copy number variation across the genome with neuropsychiatric traits in the general population
  165. Investigating late-onset ADHD: a population cohort investigation
  166. Sex-specific manifestation of genetic risk for attention deficit hyperactivity disorder in the general population
  167. A Web-Based Psychoeducational Intervention for Adolescent Depression: Design and Development of MoodHwb
  168. The impact of schizophrenia and mood disorder risk alleles on emotional problems: investigating change from childhood to middle age
  169. The presentation of depression symptoms in attention-deficit/hyperactivity disorder: comparing child and parent reports
  170. Oxytocin increases attention to the eyes and selectively enhances self-reported affective empathy for fear
  171. The WPA- Lancet Psychiatry Commission on the Future of Psychiatry
  172. Investigating the genetic underpinnings of early-life irritability
  173. Parent Psychopathology and Neurocognitive Functioning in Children With ADHD
  174. A genetic investigation of sex bias in the prevalence of attention deficit hyperactivity disorder
  175. Discovery Of The First Genome-Wide Significant Risk Loci For ADHD
  176. Irritability in ADHD: Associations with depression liability
  177. Shared genetic influences between dimensional ASD and ADHD symptoms during child and adolescent development
  178. Acetaminophen in Pregnancy and Adverse Childhood Neurodevelopment—Reply
  179. Neurodevelopmental disorders
  180. Antecedents of New-Onset Major Depressive Disorder in Children and Adolescents at High Familial Risk
  181. Intellectual Disability and Attention-Deficit/Hyperactivity Disorder: What Does the Clinical and Genetic Overlap Mean for Practice and Research?
  182. Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: a population-based cohort study
  183. Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population
  184. Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood
  185. Prevalence and correlates of psychotic experiences amongst children of depressed parents
  186. Identifying key parent-reported symptoms for detecting depression in high risk adolescents
  187. Cortisol levels at baseline and under stress in adolescent males with attention-deficit hyperactivity disorder, with or without comorbid conduct disorder
  188. Do better executive functions buffer the effect of current parental depression on adolescent depressive symptoms?
  189. Association of Genetic Risk for Schizophrenia With Nonparticipation Over Time in a Population-Based Cohort Study
  190. Pathway analysis in attention deficit hyperactivity disorder: An ensemble approach
  191. Attention deficit hyperactivity disorder
  192. Examining whether offspring psychopathology influences illness course in mothers with recurrent depression using a high-risk longitudinal sample.
  193. Salivary Oxytocin Concentrations in Males following Intranasal Administration of Oxytocin: A Double-Blind, Cross-Over Study
  194. In Reply
  195. Profiling depression in childhood and adolescence: the role of conduct problems
  196. The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome
  197. Identifying mechanisms that underlie links betweenCOMTgenotype and aggression in male adolescents with ADHD
  198. Emotion Regulation in Adolescent Males with Attention-Deficit Hyperactivity Disorder: Testing the Effects of Comorbid Conduct Disorder
  199. Correction: Association between Maternal Depression Symptoms across the First Eleven Years of Their Child's Life and Subsequent Offspring Suicidal Ideation
  200. Longitudinal symptom course in adults with recurrent depression: Impact on impairment and risk of psychopathology in offspring
  201. Pain Sensitivity in Adolescent Males with Attention-Deficit/Hyperactivity Disorder: Testing for Associations with Conduct Disorder and Callous and Unemotional Traits
  202. Association between Maternal Depression Symptoms across the First Eleven Years of Their Child’s Life and Subsequent Offspring Suicidal Ideation
  203. Parents and Genes and Their Effects on Alcohol, Drugs, and Crime in Triparental Families
  204. Pathways to Suicide-Related Behavior in Offspring of Mothers With Depression: The Role of Offspring Psychopathology
  205. Shared Genetic Influences Between Attention-Deficit/Hyperactivity Disorder (ADHD) Traits in Children and Clinical ADHD
  206. Affective bias and current, past and future adolescent depression: A familial high risk study
  207. Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
  208. The relative contribution of common and rare genetic variants to ADHD
  209. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
  210. ADHD severity is associated with white matter microstructure in the subgenual cingulum
  211. Maternal caregiving and girls' depressive symptom and antisocial behavior trajectories: An examination among high-risk youth
  212. Neurocognitive abilities in the general population and composite genetic risk scores for attention-deficit hyperactivity disorder
  213. Genetic Risk for Attention-Deficit/Hyperactivity Disorder Contributes to Neurodevelopmental Traits in the General Population
  214. Editorial Perspective: Why is there such a mismatch between traditional heritability estimates and molecular genetic findings for behavioural traits?
  215. Biological Overlap of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: Evidence From Copy Number Variants
  216. Trends in parent- and teacher-rated emotional, conduct and ADHD problems and their impact in prepubertal children in Great Britain: 1999-2008
  217. A longitudinal high‐risk study of adolescent anxiety, depression and parent‐severity on the developmental course of risk‐adjustment
  218. Reported child awareness of parental depression
  219. White Matter Microstructure Predicts Autistic Traits in Attention-Deficit/Hyperactivity Disorder
  220. Genetic variation associated with euphorigenic effects of d -amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder
  221. Antenatal Acetaminophen Use and Attention-Deficit/Hyperactivity Disorder
  222. Common adolescent mental disorders: transition to adulthood
  223. Validation of a composite of suicide items from the Mood and Feelings Questionnaire (MFQ) in offspring of recurrently depressed parents
  224. Precursors to aggression are evident by 6 months of age
  225. Genetic Associations Between the Symptoms of Attention-Deficit/Hyperactivity Disorder and Emotional Lability in Child and Adolescent Twins
  226. Commentary: Maternal pre-pregnancy BMI and offspring ADHD: a lesson in the importance of testing causal pathways
  227. Psychopathology and cognition in children with 22q11.2 deletion syndrome
  228. Detecting recurrent major depressive disorder within primary care rapidly and reliably using short questionnaire measures
  229. The Depression Impairment Scale for Parents (DISP): A new scale for the measurement of impairment in depressed parents
  230. Specific Parental Depression Symptoms as Risk Markers for New-Onset Depression in High-Risk Offspring
  231. Biological and rearing mother influences on child ADHD symptoms: revisiting the developmental interface between nature and nurture
  232. Intellectual Disability in Children with Attention Deficit Hyperactivity Disorder
  233. Depression and blood pressure in high-risk children and adolescents: an investigation using two longitudinal cohorts
  234. Parent–child hostility and child and adolescent depression symptoms: the direction of effects, role of genetic factors and gender
  235. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
  236. Copy Number Variation: What Is It and What Has It Told Us About Child Psychiatric Disorders?
  237. High Loading of Polygenic Risk for ADHD in Children With Comorbid Aggression
  238. Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia
  239. The internet is parents' main source of information about psychiatric manifestations of 22q11.2 deletion syndrome (22q11.2DS)
  240. Association between obesity and depressive disorder in adolescents at high risk for depression
  241. Maternal depression and co-occurring antisocial behaviour: testing maternal hostility and warmth as mediators of risk for offspring psychopathology
  242. Factor Structure of Autistic Traits in Children with ADHD
  243. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: Genome-wide association study of both common and rare variants
  244. A Direct Method of Assessing Underlying Cognitive Risk for Adolescent Depression
  245. Autistic traits in children with ADHD index clinical and cognitive problems
  246. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
  247. Are parental ADHD problems associated with a more severe clinical presentation and greater family adversity in children with ADHD?
  248. Examining the role of passive gene–environment correlation in childhood depression using a novel genetically sensitive design
  249. The nature of nurture: Disentangling passive genotype–environment correlation from family relationship influences on children's externalizing problems.
  250. Do parents know best? Parent-reported vs. child-reported depression symptoms as predictors of future child mood disorder in a high-risk sample
  251. The ADHD debate: being mindful of complexity and wary of reductionist explanations and polarization
  252. Shared biological risks that influence brain and behaviour
  253. Interparental conflict, parent psychopathology, hostile parenting, and child antisocial behavior: Examining the role of maternal versus paternal influences using a novel genetically sensitive research design
  254. Risk of psychopathology in adolescent offspring of mothers with psychopathology and recurrent depression
  255. Practitioner Review: What have we learnt about the causes of ADHD?
  256. Trajectories of change in self-reported psychotic-like experiences in childhood and adolescence
  257. Maternal and Paternal Smoking During Pregnancy and Risk of ADHD Symptoms in Offspring: Testing for Intrauterine Effects
  258. Missed opportunities: mental disorder in children of parents with depression
  259. Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder
  260. ‘The risks of playing it safe’: a prospective longitudinal study of response to reward in the adolescent offspring of depressed parents
  261. Review: psychological and educational interventions may reduce risk of depressive disorders in children and adolescents
  262. Depression in adolescence
  263. The association between early autistic traits and psychotic experiences in adolescence
  264. Genome-Wide Analysis of Copy Number Variants in Attention Deficit Hyperactivity Disorder: The Role of Rare Variants and Duplications at 15q13.3
  265. Investigating the Contribution of Common Genetic Variants to the Risk and Pathogenesis of ADHD
  266. Offspring of parents with recurrent depression: Which features of parent depression index risk for offspring psychopathology?
  267. Clinical and cognitive characteristics of children with attention-deficit hyperactivity disorder, with and without copy number variants
  268. Using a genetically informative design to examine the relationship between breastfeeding and childhood conduct problems
  269. Genome-wide association study in German patients with attention deficit/hyperactivity disorder
  270. What causes attention deficit hyperactivity disorder?
  271. Known Risk Factors for Violence Predict 12-Month-Old Infants’ Aggressiveness With Peers
  272. Depression screening for patients with epilepsy in a primary care setting using the Patient Health Questionnaire-2 and the Neurological Disorders Depression Inventory for Epilepsy
  273. Maternal Depression and Child and Adolescent Depression Symptoms: An Exploratory Test for Moderation by CRHR1, FKBP5 and NR3C1 Gene Variants
  274. Investigating Environmental Links Between Parent Depression and Child Depressive/Anxiety Symptoms Using an Assisted Conception Design
  275. Neurodevelopmental hypothesis of schizophrenia
  276. Prevalence of bipolar disorder in children and adolescents with attention-deficit hyperactivity disorder
  277. Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder
  278. Genotype Link With Extreme Antisocial Behavior
  279. Identifying early signs of aggression: psychometric properties of the cardiff infant contentiousness scale
  280. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis
  281. Familial transmission of depression and antisocial behavior symptoms: disentangling the contribution of inherited and environmental factors and testing the mediating role of parenting
  282. Case-Control Genome-Wide Association Study of Attention-Deficit/Hyperactivity Disorder
  283. Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder
  284. Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD)
  285. Estimating the relative contributions of maternal genetic, paternal genetic and intrauterine factors to offspring birth weight and head circumference
  286. Bipolar spectrum disorders in primary care: optimising diagnosis and treatment
  287. Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder
  288. Managing and preventing depression in adolescents
  289. Gene-Environment Interactions
  290. Psychopathy trait scores in adolescents with childhood ADHD: the contribution of genotypes affecting MAOA, 5HTT and COMT activity
  291. Should We Be Rethinking How We Assess and Manage ADHD?
  292. Prenatal Smoking Might Not Cause Attention-Deficit/Hyperactivity Disorder: Evidence from a Novel Design
  293. Dissecting the phenotype in genome-wide association studies of psychiatric illness
  294. Do prenatal risk factors cause psychiatric disorder? Be wary of causal claims
  295. Parent-child hostility and child ADHD symptoms: a genetically sensitive and longitudinal analysis
  296. Associations between maternal older age, family environment and parent and child wellbeing in families using assisted reproductive techniques to conceive
  297. The links between prenatal stress and offspring development and psychopathology: disentangling environmental and inherited influences
  298. Genomewide Association Studies: History, Rationale, and Prospects for Psychiatric Disorders
  299. Evidence-based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for Psychopharmacology
  300. An Overview on the Genetics of ADHD
  301. Disentangling prenatal and inherited influences in humans with an experimental design
  302. NK1 (TACR1) receptor gene ‘knockout’ mouse phenotype predicts genetic association with ADHD
  303. Psychopathy traits in adolescents with childhood attention-deficit hyperactivity disorder
  304. Stress, anxiety, depression, and epilepsy: Investigating the relationship between psychological factors and seizures
  305. Genetic influences on the development of childhood psychiatric disorders
  306. Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder
  307. A Replicated Molecular Genetic Basis for Subtyping Antisocial Behavior in Children With Attention-Deficit/Hyperactivity Disorder
  308. Psychopathology in children and adolescents with epilepsy: An investigation of predictive variables
  309. Parent–Child Relationships and ADHD Symptoms: A Longitudinal Analysis
  310. Mental Health and Functional Outcomes of Maternal and Adolescent Reports of Adolescent Depressive Symptoms
  311. Agreement between maternal report and antenatal records for a range of pre and peri-natal factors: The influence of maternal and child characteristics
  312. Do intrauterine or genetic influences explain the foetal origins of chronic disease? A novel experimental method for disentangling effects
  313. Effects of low birth weight, maternal smoking in pregnancy and social class on the phenotypic manifestation of Attention Deficit Hyperactivity Disorder and associated antisocial behaviour: investigation in a clinical sample
  314. Genetic and environmental influences on the relationship between peer alcohol use and own alcohol use in adolescents
  315. Advances in genetic findings on attention deficit hyperactivity disorder
  316. Exploring the relationship between genetic and environmental influences on initiation and progression of substance use
  317. The impact of gestational stress and prenatal growth on emotional problems in offspring: a review
  318. Clinical Precursors of Adolescent Conduct Disorder in Children With Attention-Deficit/Hyperactivity Disorder
  319. The Cardiff Study of All Wales and North West of England Twins (CaStANET): A Longitudinal Research Program of Child and Adolescent Development
  320. Differential dopamine receptor D4 allele association with ADHD dependent of proband season of birth
  321. Testing for gene × environment interaction effects in attention deficit hyperactivity disorder and associated antisocial behavior
  322. Gene–environment interplay in attention-deficit hyperactivity disorder and the importance of a developmental perspective
  323. The Association between Conduct Problems and the Initiation and Progression of Marijuana Use during Adolescence: A Genetic Analysis across Time
  324. Phenotypic variation between parent–offspring trios and non-trios in genetic studies of schizophrenia
  325. Twin Studies in Pediatric Depression
  326. Relationship between disabling fatigue and depression in children
  327. Family Conflict Interacts With Genetic Liability in Predicting Childhood and Adolescent Depression
  328. Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies
  329. The effect of birth-weight with genetic susceptibility on depressive symptoms in childhood and adolescence
  330. Predictors of antisocial behaviour in children with attention deficit hyperactivity disorder
  331. Catechol O-Methyltransferase Gene Variant and Birth Weight Predict Early-Onset Antisocial Behavior in Children With Attention-Deficit/Hyperactivity Disorder
  332. Do depression symptoms predict seizure frequency—or vice versa?
  333. The genetics of attention deficit hyperactivity disorder
  334. Attention deficit hyperactivity disorder with reading disabilities: preliminary genetic findings on the involvement of the ADRA2A gene
  335. The Link between Depression in Mothers and Offspring: An Extended Twin Analysis
  336. The definition of disabling fatigue in children and adolescents
  337. Relationship between antisocial behaviour, attention-deficit hyperactivity disorder and maternal prenatal smoking
  338. Twins Born Following Fertility Treatment: Implications for Quantitative Genetic Studies
  339. A Family Based Study Implicates Solute Carrier Family 1–Member 3 (SLC1A3) Gene in Attention-Deficit/Hyperactivity Disorder
  340. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD
  341. Characterizing the ADHD phenotype for genetic studies
  342. No support for association between the dopamine transporter (DAT1) gene and ADHD
  343. A family based study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD)
  344. A population-based study of anxiety as a precursor for depression in childhood and adolescence
  345. No evidence of association between Catechol-O-Methyltransferase (COMT) Val 158 Met genotype and performance on neuropsychological tasks in children with ADHD: A case-control study
  346. Prevalence of chronic disabling fatigue in children and adolescents
  347. Joint Analysis of the DRD5 Marker Concludes Association with Attention-Deficit/Hyperactivity Disorder Confined to the Predominantly Inattentive and Combined Subtypes
  348. Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD
  349. Direct analysis of the genes encoding G proteins G?T2, G?o, G?Z in ADHD
  350. Association of the Dopamine D4Receptor Gene 7-Repeat Allele With Neuropsychological Test Performance of Children With ADHD
  351. The Child Attention-Deficit Hyperactivity Disorder Teacher Telephone Interview (CHATTI): reliability and validity
  352. Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis
  353. Maternal Smoking During Pregnancy and Attention Deficit Hyperactivity Disorder Symptoms in Offspring
  354. Depressive symptoms in children and adolescents: changing aetiological influences with development
  355. Negative life events as an account of age-related differences in the genetic aetiology of depression in childhood and adolescence
  356. No evidence of association between HLA-DRB1 and attention deficit hyperactivity disorder
  357. Association between PRODH and schizophrenia is not confirmed
  358. Association analysis of monoamine oxidase a and attention deficit hyperactivity disorder
  359. Assessing the effects of age, sex and shared environment on the genetic aetiology of depression in childhood and adolescence
  360. Evidence to suggest biased phenotypes in children with Attention Deficit Hyperactivity Disorder from completely ascertained trios
  361. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT1B receptor gene in 273 nuclear families from a multi-centre sample
  362. Is primary care ready to take on Attention Deficit Hyperactivity Disorder?
  363. Association of DRD4 in children with ADHD and comorbid conduct problems
  364. The genetic aetiology of childhood depression: a review
  365. No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorder
  366. Susceptibility genes for a trait measure of attention deficit hyperactivity disorder: a pilot study in a non-clinical sample of twins
  367. Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin study design
  368. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: A family-based study
  369. Does the Definition of ADHD Affect Heritability?
  370. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder
  371. Genetic basis of attention deficit and hyperactivity
  372. Life Events and Depressive Symptoms in Childhood — Shared Genes or Shared Adversity? A Research Note
  373. Validity of the shortened Mood and Feelings Questionnaire in a community sample of children and adolescents: a preliminary research note
  374. Attention deficit hyperactivity disorder: unravelling the molecular genetics
  375. Genes and social skills
  376. Attitudes of general practitioners towards health care for people with intellectual disability and the factors underlying these attitudes
  377. Anxiety and Depressive Symptoms in Childhood?A Genetic Study of Comorbidity
  378. Genetic basis of bad behaviour in adolescents
  379. Childhood hyperactivity scores are highly heritable and show sibling competition effects: Twin study evidence
  380. Are Anxiety Symptoms in Childhood Heritable?
  381. A Twin Study of Depressive Symptoms in Childhood
  382. The Genetics of Mental Retardation
  383. The Genetics of Personality Disorder